title: Immunoaffinity MS: adding increased value through hybrid methods.
authors.affiliation: Investigative Toxicology, Eli Lilly & Company, Lilly Corporate Center, Drop Code 0720, Indianapolis, IN 46285, USA.
authors.forename: Bradley L
authors.initials: BL
authors.lastname: Ackermann
mesh_terms: D015415:Biomarkers / Q000032:analysis; D002846:Chromatography, Affinity / Q000379:methods*; D006801:Humans; D047468:Immunoprecipitation / Q000379:methods; D013058:Mass Spectrometry / Q000379:methods*; D011506:Proteins / Q000032:analysis
chemical_list: D015415:Biomarkers; D011506:Proteins
keywords: LC–MS MALDI; biotherapeutics; hybrid methods; immunoaffinity; immunoprecipitation; protein biomarkers